Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
Shamez Ladhani, Georgina Ireland, Frances Baawuah, Joanne Beckmann, Ifeanyichukwu Okike, Shazaad Ahmad, Joanna Garstang, Andrew Brent, Bernadette Brent, Felicity Aiano, Zahin Amin‐Chowdhury, Meaghan Kall, Ray Borrow, Ezra Linley, Maria Zambon, John Poh, Lenesha Warrener, Angie Lackenby, Joanna Ellis, Gayatri Amirthalingam, Kevin Brown, Mary Ramsay
Topics & Concepts
SeroprevalenceSeroconversionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakAntibodySerologyImmunologyOutbreakHuman immunodeficiency virus (HIV)Internal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies